Back to MORGAN STANLEY MORGAN STANLEY

SRPTSRPT
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in SAREPTA THERAPEUTICS INC

MORGAN STANLEY holds 2.2M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $39.6M as of 2026-Q2. The position was decreased (-15.2% shares). SRPT represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$39.6M

Current Shares

2.2M

Total Value Change

-$374.9M

Total Shares Change

-420,720

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.2M
-15.2%
$39.6M0.0%$17.97
0
2026-Q1
Increased
2.6M
+35.8%
$56.5M0.0%$15.87
38
2025-Q4
Decreased
1.9M
-1.8%
$41.2M0.0%$21.49
0
2025-Q3
Increased
1.9M
+31.0%
$37.5M0.0%$18.82
37
2025-Q2
Decreased
1.5M
-24.6%
$25.4M0.0%$17.11
0
2025-Q1
Increased
2M
+98.9%
$125.9M0.0%$70.41
49
2024-Q4
Increased
991,655
+4.0%
$120.6M0.0%$121.19
31
2024-Q3
Decreased
953,104
-63.7%
$119M0.0%$124.53
0
2024-Q2
New
2.6M
-
$414.5M0.0%$158.00
43

Other major holders of SRPT: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., Janus Henderson Group Ltd., BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used